Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) was up 29.3% on Friday . The company traded as high as $0.23 and last traded at $0.22. Approximately 10,000 shares were traded during mid-day trading, an increase of 65% from the average daily volume of 6,075 shares. The stock had previously closed at $0.17.
Viva Biotech Price Performance
The business’s fifty day moving average is $0.11 and its two-hundred day moving average is $0.11.
About Viva Biotech
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions.
Further Reading
- Five stocks we like better than Viva Biotech
- 3 REITs to Buy and Hold for the Long Term
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- How to Calculate Stock Profit
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Stock Sentiment Analysis: How it Works
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
